Medidata is leading the digital transformation of life sciences, creating hope for millions of patients worldwide. Medidata generates the evidence and insights needed to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,900+ customers access the world’s most trusted platform for clinical development. Medidata Acorn AI combines superior cross industry clinical trial data with a unified platform, advanced analytics and deep industry expertise to help propel life sciences forward. . Built upon the Medidata platform comprising 25,000+ trials and more than seven million patients, Acorn AI products feature the industry’s largest structured, standardized clinical trial data repository connected with real-world, commercial, and other datasets to help re-think the limits of what is possible. Medidata, a Dassault Systèmes company is headquartered in New York City and has offices around the world to meet the needs of its customers.
Medidata and HealthVerity have complementary offerings that empower life science companies to maximize the impact to patients at the intersection of RWD and Clinical Trials. This partnerships efficiently enables Trial patient tokenization on the Medidata Rave EDC platform to enhance trial data with RWD before, during, and after the trial period and provides data inputs for advanced analytics.